Publications

Publications

Discover content that is distributed for public review, including online articles, magazine reports, and medical journal broadcasts that provide a snapshot of AVITA Medical and our mission from the vantagepoint of researchers, clinicians, and patients throughout the world.

JOIN OUR COMMUNITY

BE THE FIRST TO RECEIVE NEWS, UPDATES, AND EVENT INFORMATION FROM AVITA MEDICAL.

RECELL® SYSTEM OUS IMPORTANT SAFETY INFORMATION

INDICATIONS FOR USE: RECELL® is indicated for harvesting of skin cells from a patient’s split-thickness skin samples, for reintroduction to the patient.  Please see the Instructions for Use for each country for specific indication use of RECELL.

CONTRAINDICATIONS: RECELL® are contraindicated for treatment of infected wounds

or with necrotic tissue present in the wound bed, and for patients having unstable vitiligo or a known hypersensitivity to anesthetics, adrenaline/epinephrine, povidine-iodine, or chlorhexidine solutions.

WARNINGS AND PRECAUTIONS: Regenerative Epidermal Suspension (RESTM ) prepared using the RECELL® Device should only be applied to patients from whom the original skin sample was taken. RECELL® is provided sterile and is intended for single-use. Do not use if packaging is damaged or expired. A skin sample should require between 15 and 30 minutes contact with the Enzyme. Contact in excess of 60 minutes is not recommended. RECELL® Enzyme is animal derived and freedom from infectious agents cannot be guaranteed. RESTM should be applied to a clean, dry, haemostatic vascularized wound bed.

For complete Important Safety Information refer to Instructions For Use for specific countries.

ADVERSE REACTIONS Any adverse reaction or suspected adverse reaction related to RECELL® ReCell should immediately be reported to Avita Medical.

*In all countries outside of Europe, our portfolio is marketed under the RECELL® brand to promote skin healing in a wide range of applications including burns, chronic wounds and aesthetics. RECELL® is TGA-registered in Australia, CFDA-cleared in China and CE-mark in Europe. In the United States, RECELL® is not approved for sale and is limited by federal law to investigational use.

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.